Smith & Nephew (SN) Competitors

Smith & Nephew (LON:SN) and Haleon (LON:HLN) are both large-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, institutional ownership, risk, valuation, earnings, profitability, community ranking, media sentiment and analyst recommendations.

Is SN or HLN more profitable?

Haleon has a net margin of 9.66% compared to Smith & Nephew's net margin of 5.41%. Haleon's return on equity of 6.54% beat Smith & Nephew's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Smith & Nephew	5.41%	5.85%	4.51%
Haleon	9.66%	6.54%	4.45%

Which has more risk and volatility, SN or HLN?

Smith & Nephew has a beta of 0.62, suggesting that its stock price is 38% less volatile than the S&P 500. Comparatively, Haleon has a beta of 0.19, suggesting that its stock price is 81% less volatile than the S&P 500.

Do institutionals and insiders have more ownership in SN or HLN?

62.2% of Smith & Nephew shares are owned by institutional investors. Comparatively, 43.9% of Haleon shares are owned by institutional investors. 0.2% of Smith & Nephew shares are owned by insiders. Comparatively, 10.7% of Haleon shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Is SN or HLN a better dividend stock?

Smith & Nephew pays an annual dividend of GBX 29 per share and has a dividend yield of 2.9%. Haleon pays an annual dividend of GBX 6 per share and has a dividend yield of 1.6%. Smith & Nephew pays out 104.4% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Haleon pays out 50.5% of its earnings in the form of a dividend.

Do analysts recommend SN or HLN?

Smith & Nephew presently has a consensus price target of GBX 4,607.50, indicating a potential upside of 362.60%. Haleon has a consensus price target of GBX 457, indicating a potential upside of 21.35%. Given Smith & Nephew's higher probable upside, equities analysts plainly believe Smith & Nephew is more favorable than Haleon.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Smith & Nephew	0 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	3.00
Haleon	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Which has higher earnings & valuation, SN or HLN?

Haleon has higher revenue and earnings than Smith & Nephew. Haleon is trading at a lower price-to-earnings ratio than Smith & Nephew, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Smith & Nephew	£7.08B	1.54	£382.79M	£27.77	35.86
Haleon	£11.07B	3.07	£1.07B	£11.89	31.67

Does the MarketBeat Community favor SN or HLN?

Smith & Nephew received 548 more outperform votes than Haleon when rated by MarketBeat users. Likewise, 62.02% of users gave Smith & Nephew an outperform vote while only 31.58% of users gave Haleon an outperform vote.

Company	Underperform	Outperform
Smith & Nephew	Outperform Votes 560 62.02%	Underperform Votes 343 37.98%
Haleon	Outperform Votes 12 31.58%	Underperform Votes 26 68.42%

Does the media favor SN or HLN?

In the previous week, Smith & Nephew had 4 more articles in the media than Haleon. MarketBeat recorded 5 mentions for Smith & Nephew and 1 mentions for Haleon. Haleon's average media sentiment score of 1.08 beat Smith & Nephew's score of 0.11 indicating that Haleon is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Smith & Nephew	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral
Haleon	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Smith & Nephew beats Haleon on 11 of the 19 factors compared between the two stocks.